Private respiratory clinics in Australia are overpaying for software. The culprit is rarely the headline subscription price; it is the hidden ecosystem of costs that vendor-locked systems quietly accumulate: proprietary device fees, IT infrastructure, duplicate data entry, and costly contract renewals. Switching to a vendor-neutral, cloud-based platform eliminates most of these layers. This guide breaks down exactly where the savings come from and what to look for when evaluating your next respiratory software platform.

TL;DR

• Vendor lock-in is the single biggest driver of inflated software costs in respiratory clinics.

• Hidden costs (IT infrastructure, device-specific licensing, manual workarounds) routinely dwarf the base subscription fee.

• Cloud-based, vendor-neutral platforms can realistically reduce total software spend by 30-40%.

• Australia's respiratory sector is under funding and access pressure, making operational efficiency more critical than ever.

• A structured sourcing checklist helps clinics avoid repeating the same costly mistakes when switching platforms.

Why Are Private Respiratory Clinics Overpaying for Software Right Now?

Overpaying for clinical software is not a budgeting failure; it is a structural problem baked into how most respiratory software has historically been sold. Traditional platforms were built by device manufacturers, which means the software was never really the product. The device was. The software was the mechanism that kept you buying that manufacturer's equipment.

This creates a cost structure that compounds over time:

• Device-tied licensing: Many legacy systems charge per-device or per-manufacturer connection fees.

• On-premise server costs: Local installations require hardware, IT maintenance, security patching, and eventual replacement cycles.

• Manual data re-entry: When software cannot talk to all your devices, staff manually re-enter results, which is both a cost and a clinical risk.

• Upgrade fees: Major version upgrades are often sold as separate purchases rather than included in ongoing subscriptions.

• Contract lock-in: Multi-year contracts with steep exit clauses remove any negotiating leverage at renewal time.

The National Asthma Council Australia noted in 2025 that Australia's respiratory sector is being hamstrung by chronic underfunding and poor data visibility. When operational costs are already under pressure, software inefficiency is not a minor inconvenience; it actively limits the care a clinic can deliver.

What Is Vendor Lock-In and Why Does It Cost So Much?

Vendor lock-in is a situation where a clinic becomes so dependent on a single supplier's ecosystem that switching platforms becomes prohibitively expensive or operationally disruptive, regardless of whether the current solution is still the best fit.

In respiratory software, lock-in typically manifests in three ways:

The practical result is that clinics continue paying above-market rates not because the software is worth it, but because leaving feels harder than staying.

Where Do the Real Cost Savings Come From in a Vendor-Neutral Platform?

The 40% figure is not theoretical. It reflects the cumulative removal of costs that most clinics do not itemise separately but are paying regardless.

1. Eliminate device-specific licensing
A vendor-neutral platform accepts data from any manufacturer's equipment. This means you are not paying a premium to connect a spirometer from one brand and a CPAP device from another.

2. Remove on-premise IT overhead
A fully cloud-based SaaS platform removes the need for local servers, dedicated IT support contracts, hardware refresh cycles, and on-site backup infrastructure. For a small-to-mid-sized private clinic, this alone can represent a meaningful annual saving.

3. Reduce staff time lost to manual processes
Automated data import, structured reporting templates, and integrated workflows reduce the time scientists and admin staff spend on non-clinical tasks. Time is a direct cost.

4. Consolidate systems
Many clinics are running separate tools for patient administration, reporting, accreditation management, and billing. A platform that covers all of these in a single monthly fee replaces multiple subscriptions.

5. Transparent, all-inclusive pricing
Month-to-month pricing with no lock-in contracts means you are never trapped. You retain leverage, and the vendor is incentivised to keep earning your business.

What Should a Sourcing Checklist for Respiratory Software Include?

When evaluating a new platform, the goal is to assess total cost of ownership, not just the subscription price. Use this checklist:

Compatibility and Integration

• Does it accept data from all your current devices regardless of manufacturer?

• Does it integrate with your Patient Administration System (PAS) and Electronic Medical Record (EMR)?

• Does it support DICOM Modality Worklists and electronic ordering?

Clinical Functionality

• Is reporting aligned with ATS (American Thoracic Society) guidelines?

• Does it include a regularly updated normal values library?

• Does it support both respiratory and sleep reporting in one platform?

Accreditation and Compliance

• Does it include tools for TSANZ/NATA accreditation and ISO 15189 requirements?

• Does it cover document management, non-conformance tracking, and quality control?

Infrastructure and IT

• Is it fully cloud-based with no local server requirement?

• What is the data security and privacy framework? (Under the Privacy Act 1988, health service providers carry specific obligations around patient data, as outlined by the OAIC.)

Commercial Terms

• Is pricing all-inclusive with no hidden per-device or per-module fees?

• Is there a no lock-in contract option?

• Is a free trial available before committing?

Vendor Stability

• How long has the vendor been operating in this space?

• Do they have a verifiable client base in Australian public and private settings?

Is Switching Platforms as Disruptive as Clinics Fear?

This is the most common reason clinics delay switching, and it is worth addressing directly. The fear of data migration and workflow disruption is usually larger than the reality, particularly when moving to a modern cloud platform.

A well-designed migration process typically involves:

1. Data export from your existing system in a standard or agreed format.

2. Structured import into the new platform, with validation checks to confirm data integrity.

3. Parallel running for a defined period so staff can build confidence before full cutover.

4. Training and onboarding, which on a well-designed platform is measured in days, not weeks.

The key is choosing a vendor who has done this before and can demonstrate a clear migration pathway. Clinics that have moved from legacy systems like Respiro to platforms like Rezibase have found the transition straightforward, particularly because cloud-based platforms do not require any local installation or IT configuration on the clinic's side.

How Is the Broader Australian Respiratory Landscape Shaping Software Decisions?

Two trends are accelerating the shift toward flexible, vendor-neutral platforms.

First, access to specialist respiratory care is under structural pressure. The Grattan Institute's 2025 report on specialist care access highlighted the need to modernise public clinics and reduce inefficiencies across the system. Private clinics that operate efficiently are better positioned to absorb referral demand as the public system works through its own constraints.

Second, telehealth is becoming a standard delivery channel. The RACGP reported in 2025 that best-practice telehealth principles are being formalised for Australian providers. Respiratory platforms that are cloud-native are inherently better suited to support hybrid and remote care models than on-premise legacy systems.

A 2025 study published in BMC Health Services Research also highlighted gaps in respiratory service delivery in underserved communities, pointing to spirometry and structured reporting as foundational services. Clinics that can deliver these efficiently and at lower cost are in a stronger position to expand their reach.

Frequently Asked Questions

How much can a private respiratory clinic realistically save by switching platforms?
Savings vary by clinic size and current setup, but removing on-premise IT costs, device licensing fees, and manual workflow overhead can realistically reduce total software spend by 30-40%.

Does vendor-neutral mean the software works with all spirometry and sleep devices?
Yes. A truly vendor-neutral platform imports data from any manufacturer's equipment without requiring proprietary connections or additional licensing.

What happens to our existing patient data when we switch?
Patient data can be migrated from your existing system. A structured import process with validation checks ensures data integrity. The process is simpler than most clinics expect.

Do cloud-based respiratory platforms meet Australian privacy requirements?
They must. Under the Privacy Act 1988, health service providers are required to protect patient health information. Reputable platforms are designed with these obligations built in.

Is a month-to-month contract really available for enterprise-grade respiratory software?
Yes, with the right vendor. Rezibase, for example, offers transparent all-inclusive monthly pricing with no lock-in contracts and a 30-day free trial.

Does the platform need to support both respiratory and sleep to be worth switching?
If your clinic handles both, yes. Running separate systems for respiratory and sleep doubles your administrative overhead and integration complexity.

How long does onboarding typically take?
For a cloud-based platform with a well-designed onboarding process, most clinics are operationally live within a few weeks, not months.

About Rezibase

Rezibase is Australia's most advanced cloud-based respiratory and sleep reporting platform, built by respiratory scientists for respiratory scientists. Trusted by over 35 sites including NSW Health and the NHS in the UK, Rezibase offers a vendor-neutral, all-inclusive SaaS solution with no lock-in contracts, a 30-day free trial, and the depth of functionality to support everything from clinical reporting to TSANZ/NATA accreditation. Learn more at rezibase.com.

Ready to see what your clinic could save? Explore Rezibase and start your free 30-day trial at rezibase.com.

References

• Grattan Institute. Special treatment: Improving Australians' access to specialist care. https://grattan.edu.au/report/special-treatment-improving-australians-access-to-specialist-care/

• Springer Nature Link. Scanning the respiratory service landscape in NSW-based Aboriginal Community Controlled Health Services. https://link.springer.com/article/10.1186/s12913-025-13361-w

• National Asthma Council Australia. Lives compromised, cut short as Australia fails to fully fund respiratory research. https://www.nationalasthma.org.au/news/2025/lives-compromised-cut-short-as-australia-fails-to-fully-fund-respiratory-research

• RACGP. Telehealth provider publishes 'best-practice' principles. https://www1.racgp.org.au/newsgp/professional/telehealth-provider-publishes-best-practice-princi

• OAIC. Guide to health privacy. https://www.oaic.gov.au/privacy/privacy-guidance-for-organisations-and-government-agencies/health-service-providers/guide-to-health-privacy